Cadonilimab for uterine cervical neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 29 Jul 2021: Trial registered, NCT04982237
  2. 27 Aug 2021: Trial started, NCT04982237

The trials

NCT04982237: A Study of AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer

State
Under way
Phase
Phase 3
People
445 taking part
Started
27 Aug 2021
Primary completion
30 Dec 2025
Arms
AK104+chemotherapy± bevacizumab
Results
None posted
  1. 29 Jul 2021: Trial registered
  2. 27 Aug 2021: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.